David Tousley joins board of advisors at Madeira
This article was originally published in Scrip
Madeira Therapeutics (US), a new drug development company specialising in paediatric pharmaceuticals, has appointed David Tousley to its board of advisors. Mr Tousley is the principal of Stratium Consulting Services, assisting companies with strategic and financial planning and management.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.